Latest Biotech News

CMS launched a voluntary payment model designed to broaden Medicare coverage of GLP‑1 weight‑loss drugs. The agency announced the model as a step to increase beneficiary access and address drug...

The FDA approved Omeros’s complement‑system drug Yartemlea to treat a severe, potentially fatal complication of hematopoietic stem cell transplants, marking the first regulatory clearance for this...

Johnson & Johnson halted development of an experimental eczema therapy it acquired for $1.25 billion, citing efficacy shortfalls in internal testing. The decision ends expectations tied to the...

Recent research released new insights into neurotoxicity associated with CAR‑T cell therapies. The work maps clinical patterns and potential biological pathways underpinning neurological adverse...

A new meta‑analysis compared CAR‑T therapies with bispecific antibodies in relapsed or refractory indolent B‑cell non‑Hodgkin’s lymphoma, synthesizing efficacy and safety across published trials....

Researchers discovered a class of potent antibodies that cross‑neutralize the Marburg virus and the related Ravn virus, reporting results in npj Viruses. The antibodies show broad activity against...

Researchers reported engineered nanovaccine platforms aimed at hepatocellular carcinoma (HCC) immunotherapy, describing design features that improve antigen presentation and immune stimulation in...

A new design framework for adeno‑associated virus (AAV) vectors enables dynamic responses to tumor microenvironment cues, improving tumor targeting and intratumoral delivery in preclinical models....

SpatialBench introduced a benchmark suite of 146 verifiable problems drawn from authentic spatial biology workflows to evaluate agent‑style models on spatial assay analysis. The benchmark spans...

Deep learning models developed for gastric cancer prognosis and immunotherapy response prediction showed improved risk stratification using digital pathology. The study, published in the Journal...

CMS launched a voluntary payment model designed to expand Medicare coverage of GLP‑1 weight‑loss drugs by testing alternative payment and reimbursement structures for participating plans and...

The FDA granted approval to Omeros’s complement inhibitor Yartemlea for treating a severe, potentially fatal complication of hematopoietic stem cell transplants, marking the first approved therapy...

Johnson & Johnson announced it is discontinuing development of the eczema candidate JNJ‑5939 (NM26) acquired in a $1.25 billion deal, after the drug failed to meet efficacy thresholds in a Phase 2...

A new meta‑analysis compared CAR‑T therapies with bispecific antibodies for relapsed or refractory indolent B‑cell non‑Hodgkin’s lymphomas, synthesizing outcomes across trials to clarify efficacy...

Researchers reported discovery of a class of potent, cross‑neutralizing monoclonal antibodies that neutralize the Marburg virus and the related Ravn virus, according to a study published in npj...

Scientists unveiled an intelligent design framework for adeno‑associated virus (AAV) vectors that dynamically respond to tumor microenvironment cues to improve tumor targeting and intratumoral...

SpatialBench, introduced in a new paper, offers a suite of 146 verifiable problems drawn from real spatial biology workflows across five platforms (MERFISH, Seeker, Visium, Xenium, ATLASxomics...

Researchers presented nanovaccine platforms engineered to prime immune responses against hepatocellular carcinoma (HCC), detailing antigen delivery, adjuvant selection and tumor‑site activation...

A recent report consolidated advances in understanding CAR‑T associated neurotoxicity, outlining cellular and molecular mechanisms implicated in immune effector cell‑associated neurotoxicity...

A broad review examined targeted protein degradation technologies and their implications for human health and non‑human species, mapping therapeutic opportunities and potential ecological or...